文献速递临床试验与 GCP流行病学与生物统计

评估有风险因素青少年的初级自杀预防(ESPAIR):整群随机对照试验研究方案

Evaluating primary suicide prevention in adolescents with risk factors (ESPAIR): study protocol for a cluster-randomized controlled trial.
PubMed 文献 · Trials · 2025-11-24

ESPAIR为开放标签、多中心、优效性、整群随机对照试验,在至少8个研究点按1:1随机分配基于心理教育的初级自杀预防干预与艺术对照干预。招募14-25岁高风险青少年共240例,主要结局为自杀意识,随访至3个月,采用意向性分析混合效应模型。

要点

  • 研究对象为14-25岁具有高风险因素(如被拘留、失学、精神科治疗等)的青少年。
  • 主要结局为量表测量的自杀意识,次要结局包括自杀知识、心理痛苦及安全性等。
  • 采用整群随机、开放标签、多中心优效性设计,至少8个研究点,总样本量240例。

核心结论

  • 研究者预期简短的初级自杀预防干预(心理教育)在脆弱青少年中有效且安全。

研究设计与样本

  • 开放标签、多中心、优效性、整群随机对照试验,两个平行组按1:1随机分配,至少8个研究点。
  • 招募14-25岁高风险青少年共240例,包括被拘留于少年拘留中心、失学、精神科治疗中、性少数或性别多样化、受慢性疾病影响、有家庭关系问题者。
  • 干预组接受基于心理教育的初级自杀预防干预,对照组接受艺术对照干预。
  • 主要结局为经验证量表测量的自杀意识,次要结局包括自杀知识、对当地资源的了解、自杀行为、心理痛苦、获得初级自杀预防服务及安全性。
  • 在基线、1周和3个月随访时收集测量,采用意向性分析混合效应模型。

主要发现

  • 原文未报告研究结果。

关键数值与推荐

  • 主要结局为自杀意识,采用经验证量表测量。
  • 次要结局包括自杀知识、对当地资源的了解、自杀行为、心理痛苦、获得初级自杀预防服务及安全性。
  • 测量时间点为基线、1周和3个月随访。
  • 试验注册号ClinicalTrials.gov NCT06551038,注册日期2024年8月13日。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Suicide is the leading cause of death among young people. Because it is preventable, suicide prevention has become a critical public health priority worldwide. Current evidence suggests that primary suicide prevention interventions are effective in promoting suicide awareness and reducing suicidal thoughts among adolescents. However, scarce research has been conducted in vulnerable populations who may be at increased risk of suicidal behaviour. This project aims to test the effectiveness of a primary suicide prevention intervention on suicide awareness, knowledge of suicide and local resources, suicidal thoughts, psychological distress, and safety. METHODS: This study is an open-label, multi-centre, superiority, cluster-randomized controlled trial with two parallel arms (randomization 1:1 in at least 8 study sites) of a primary suicide prevention intervention based on psychoeducation versus an art-based control intervention. Four groups of youth aged 14-25 with high suicide risk will be recruited (in total, n = 240), including those (1) detained in juvenile detention centres, (2) disconnected from school, (3) in treatment for psychiatric disorders, (4) belonging to a sexual or gender diversity, (5) affected by chronic conditions, and (6) with relational/familial problems. Participants will be randomly assigned to the suicide prevention or control intervention. The primary outcome is suicide awareness measured on a validated scale. Secondary outcomes include knowledge of suicide, knowledge of local resources, suicidal behaviour, psychological distress, access to primary suicide prevention, and safety. Measures will be collected at baseline, at 1-week, and 3-month follow-ups. Analyses will be conducted as intention-to-treat using mixed-effects models. DISCUSSION: We expect that a brief primary suicide prevention intervention (psychoeducation) will be effective and safe in vulnerable adolescents. TRIAL REGISTRATION: ClinicalTrials.gov NCT06551038. Registered on August 13, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Baggio S, Bailey E, Edan A, et al. Evaluating primary suicide prevention in adolescents with risk factors (ESPAIR): study protocol for a cluster-randomized controlled trial. Trials. 2025. PMID: 41286939. doi:10.1186/s13063-025-09266-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。